These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24329148)

  • 21. Recovering fraudulent claims for Australian federal expenditure on pharmaceuticals and medical devices.
    Faunce T; Urbas G; Skillen L; Smith M
    J Law Med; 2010 Dec; 18(2):302-15. PubMed ID: 21355432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving availability and affordability of plasma-derived medicines.
    Cheraghali AM; Abolghasemi H
    Biologicals; 2010 Jan; 38(1):81-6. PubMed ID: 20137973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.
    Kokabisaghi F
    Int J Health Policy Manag; 2018 May; 7(5):374-393. PubMed ID: 29764102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of the Sanctions Made Against Iran on Availability to Asthma Medicines in Tehran.
    Ghiasi G; Rashidian A; Kebriaeezadeh A; Salamzadeh J
    Iran J Pharm Res; 2016; 15(3):567-571. PubMed ID: 27980593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iran: Lift sanctions now to save public health.
    Aloosh M; Aloosh A
    Nature; 2015 Apr; 520(7549):623. PubMed ID: 25925468
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost containment through pharmaceutical procurement: a Caribbean case study.
    Huff-Rousselle M; Burnett F
    Int J Health Plann Manage; 1996; 11(2):135-57. PubMed ID: 10172681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of economic sanctions on access to noncommunicable diseases medicines in the Islamic Republic of Iran.
    Kheirandish M; Varahrami V; Kebriaeezade A; Cheraghali AM
    East Mediterr Health J; 2018 Apr; 24(1):42-51. PubMed ID: 29658620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
    Cohen-Kohler JC; Forman L; Lipkus N
    Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WHO responds to the Iraqi ministry of health's urgent call for medicines and medical supplies.
    Ann Saudi Med; 2004; 24(6):494-5. PubMed ID: 15646180
    [No Abstract]   [Full Text] [Related]  

  • 30. Public procurement of health technologies in Greece in an era of economic crisis.
    Kastanioti C; Kontodimopoulos N; Stasinopoulos D; Kapetaneas N; Polyzos N
    Health Policy; 2013 Jan; 109(1):7-13. PubMed ID: 22502936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. US Sanctions against Iran; an Irreversible Disaster for Cancer Patients.
    Barzegartahamtan M; Mahdavi SR; Haddad P
    Arch Iran Med; 2020 Aug; 23(8):572. PubMed ID: 32894973
    [No Abstract]   [Full Text] [Related]  

  • 32. A news media analysis of economic sanction effects on access to medicine in Iran.
    Kheirandish M; Rashidian A; Bigdeli M
    J Res Pharm Pract; 2015; 4(4):199-205. PubMed ID: 26645026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualitative analysis of national documents on health care services and pharmaceuticals` purchasing challenges: evidence from Iran.
    Bastani P; Samadbeik M; Dinarvand R; Kashefian-Naeeini S; Vatankhah S
    BMC Health Serv Res; 2018 Jun; 18(1):410. PubMed ID: 29871679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policies and measures implemented to reduce the impact of international sanctions on Iran's pharmaceutical sector.
    Emami F; Cheraghali AM
    Res Pharm Sci; 2022 Jun; 17(3):274-283. PubMed ID: 35531135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human cost of economic sanctions and strategies for building health system resilience: A scoping review of studies in Iran.
    Sajadi HS; Yahyaei F; Ehsani-Chimeh E; Majdzadeh R
    Int J Health Plann Manage; 2023 Sep; 38(5):1142-1160. PubMed ID: 37194133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Massachusetts city attempts to import drugs form Canada.
    Caroll J
    Manag Care; 2003 Oct; 12(10):16-7. PubMed ID: 14598537
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of the international economic sanctions on access to medicine of the Iranian people: A systematic review.
    Asadi-Pooya AA; Nazari M; Damabi NM
    J Clin Pharm Ther; 2022 Dec; 47(12):1945-1951. PubMed ID: 36401156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic sanctions as human rights violations: reconciling political and public health imperatives.
    Marks SP
    Am J Public Health; 1999 Oct; 89(10):1509-13. PubMed ID: 10511832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.